A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.

Clinical transplants

Volumn , Issue , 2012, Pages 155-166

  Abu Elmagd, Kareem M ^a   Costa, Guilherme ^b   Bond, Geoffrey J ^b   Soltys, Kyle ^b   Martin, Lillian ^b   Koritsky, Darlene A ^b   Cunha Melo, Jose R ^b   Sogawa, Hiroshi ^b   Irish, William ^b   Tzakis, Andreas ^b   Mazariegos, George ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEMTUZUMAB; ANTINEOPLASTIC AGENT; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ALLOTRANSPLANTATION; ANIMAL; ARTICLE; DRUG EFFECT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; INCIDENCE; INFECTION; INTESTINE; MALE; MIDDLE AGED; MORBIDITY; MORTALITY; PANCREAS TRANSPLANTATION; RABBIT; STOMACH; TRANSPLANTATION;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTILYMPHOCYTE SERUM; ANTINEOPLASTIC AGENTS; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFECTION; INTESTINES; MALE; MIDDLE AGED; MORBIDITY; PANCREAS TRANSPLANTATION; RABBITS; STOMACH; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 84879148111     PISSN: 08909016     EISSN: None     Source Type: None    
DOI: None     Document Type: Article

References (0)